"Combination of Mitoxantrone Hydrochloride Liposome with Cyclophosphamide, Vincristine and Prednisone (CMOP) in Treatment-Naive Patients with Peripheral T-Cell Lymphoma: A Multicenter, Open-Label, Single-Arm, Phase Ib Clinical Trial"

作者全名："Huang, Hui-Qiang; Yan, Gao; Jiang, Ming; Liu, Lihong; Xiao, Qing; Li, Yufu; Zhou, Hui; Xue, Jianfei; Wang, Dong; Xie, Dapeng; Li, Honglian; Wang, Peng"

作者地址："[Huang, Hui-Qiang] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China; [Yan, Gao] Sun Yat Sen Univ, Canc Ctr, Dept Med Oncol, Guangzhou, Peoples R China; [Jiang, Ming] Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China; [Liu, Lihong] Hebei Med Univ, Hosp 4, Dept Hematol, Shijiazhuang, Hebei, Peoples R China; [Xiao, Qing] Chongqing Med Univ, Affilicated Hosp 1, Chongqing, Peoples R China; [Li, Yufu] Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Dept Hematol, Zhengzhou, Peoples R China; [Zhou, Hui] Cent South Univ, Xiangya Med Sch, Hunan Canc Hosp, Affiliated Tumor Hosp,Dept Lymphoma & Hematol, Changsha, Peoples R China; [Xue, Jianfei] CSPC ZhongQi Pharmaceut Technol Shijiazhuang Co L, Shijiazhuang, Hebei, Peoples R China; [Wang, Dong] CSPC Zhongqi Pharmaceut Technol Shijiazhuang Ltd, Guangzhou, Peoples R China; [Xie, Dapeng; Wang, Peng] CSPC Zhongqi Pharmaceut Technol Shijiazhuang Ltd, Shanghai, Peoples R China"

通信作者：　

来源：BLOOD

ESI学科分类：CLINICAL MEDICINE

WOS号：WOS:000893223203350

JCR分区：Q1

影响因子：20.3

年份：2022

卷号：140

期号：　

开始页：3762

结束页：3763

文献类型：Meeting Abstract

关键词：　

摘要：　

基金机构：　

基金资助正文：